EPFL Investor Day 2024

10 Dec 2024 | Lausanne, Switzerland

Patrick Kessel

CEO

PERIVISION SA

Lausanne, Switzerland

21 profile visitsSpeaker

CEO & co-founder at PeriVision, a Swiss medtech startup. Strategy consultant-turned-entrepreneur with a passion for healthcare innovation.

My organisation

PERIVISION SA

PERIVISION SA

Startup

Lausanne, Switzerland

2.2 billion people suffer from vision impairments of which 50% could be prevented or cured according to the World Health Organization. This number is growing due to our ageing populations and modern lifestyles. ​Current testing standards are not fit for the 21st century. They require stationary and resource-intense workflows and often produce limited insights. This leads to bottlenecks in clinics and limited patient access to eye testing & adequate treatment.  We want to change that and make eye testing & care accessible to everyone - everywhere. For this, PeriVision combines artificial intelligence (AI), virtual reality (VR) and the cloud to build the next generation systems to test and understand visual function.
Read more

About me

Patrick Kessel holds a B.A. in Business Administration from the University of St. Gallen (HSG), including an exchange semester at Singapore Management University (SMU), and a MSc. in Political Science (Distinction) from the London School of Economics & Political Science (LSE). He is also a certified Scrum Master. Prior to joining PeriVision, he advised medtech, biopharma and insurance clients on business development, go-to-market strategy, digitization and operations optimization at the Boston Consulting Group (BCG). While at BCG, he initiated the firm’s tech startup support program “BCG Startup Unlock” to provide pro-bono strategy consulting to Swiss technology startups.

My organisation

At PeriVision, we build VR eye tests and AI diagnostics & prognostics tools to address the large unmet need for more efficient and patient-friendly eye tests. Our platform improves clinic productivity, insights for clinical decisions and patient access. We have 3 regulatory approvals, ~CHF 0.6M revenue for 2024 and a world-class team. I'd love to meet for a chat about our seed round.

Social media

Speaker sessions (1)

Tuesday, 10 December 2024

10:15 - 11:20

Pitch Sessions Healthtech

Format:In-personLocation:Pitch Area 1Track:Pitch Session

Experience the forefront of healthtech innovation at EPFL Investor Day!